Atlas company financials

CHEMED CORP

Standardized 18-year financial series for CHEMED CORP, built from filing-derived source data and exposed in JSON, CSV, and XLSX so it can feed iterFact artifacts or analyst workflows without hand-entering the numbers.

United StatesCIK 0000019584FY2008 → FY2025

Open JSON Download CSV Download XLSX Quarterly JSON Summary JSON Filing index

Latest fiscal year

FY2025

Revenue

$2.5B

Adjusted EBITDA

—

Net result

$265.2M

Net financial debt

—

Latest source: FY2025 filing · published data snapshot generated April 26, 2026

Phase 2 summary

Latest quarter, TTM, and growth are now pre-computed for chat and templates.

Latest quarter revenue

$624.9M

TTM revenue

$2.5B

TTM free cash flow

—

Latest quarter net result

$64.2M

Quarterly coverage: 50 periods · latest quarter FY2025-Q3 · TTM revenue growth 35.7%.

What this gives you

A proof-of-concept company data surface, not a dead PDF shelf.

The same standardized payload behind this page is exposed through downloadable CSV and XLSX files plus a stable JSON route. That makes it usable as a live input to iterFact templates, a spreadsheet handoff, or a future API surface without re-normalizing the source documents again.

Source audit

Official links first, raw iterFact payloads right next to them.

Official sources

SEC EDGAR companyfacts
comparative · chemed-corp-fy2008 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2011-02-28 · Retrieved: 2026-04-26T11:52:35.882743+00:00
SEC EDGAR companyfacts
primary · chemed-corp-fy2011 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2012-02-27 · Retrieved: 2026-04-26T11:52:35.882743+00:00
SEC EDGAR companyfacts
primary · chemed-corp-fy2012 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2013-02-27 · Retrieved: 2026-04-26T11:52:35.882743+00:00
SEC EDGAR companyfacts
primary · chemed-corp-fy2013 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2014-02-27 · Retrieved: 2026-04-26T11:52:35.882743+00:00
SEC EDGAR companyfacts
primary · chemed-corp-fy2014 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2015-02-27 · Retrieved: 2026-04-26T11:52:35.882743+00:00

Ten-year series

Headline company financials by fiscal year

Fiscal year	Revenue	Adj. EBITDA	EBIT	Net result	Op. cash flow	Capex	Net debt	Status
FY2008	1B	—	133M	67M	112M	-26M	—	comparative annual fact carried from later 10k · missing accounts receivable · missing adjusted ebitda · missing current assets · missing current liabilities · missing gross profit · missing inventory · missing net financial debt · missing research and development · missing total assets
FY2009	1B	—	126M	74M	161M	-21M	40M	comparative annual fact carried from later 10k · missing adjusted ebitda · missing gross profit · missing research and development
FY2010	1B	—	144M	82M	86M	-26M	109M	missing adjusted ebitda · missing gross profit · missing research and development
FY2011	1B	—	154M	86M	174M	-30M	129M	missing adjusted ebitda · missing gross profit · missing research and development
FY2012	1B	—	156M	89M	132M	-35M	105M	missing adjusted ebitda · missing gross profit · missing research and development
FY2013	1B	—	133M	77M	151M	-29M	283M	missing adjusted ebitda · missing gross profit · missing research and development
FY2014	1B	—	168M	99M	110M	-44M	133M	missing adjusted ebitda · missing gross profit · missing research and development
FY2015	2B	—	184M	110M	172M	-44M	77M	missing adjusted ebitda · missing gross profit · missing research and development
FY2016	2B	—	179M	109M	135M

Filing provenance